from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0688/-

LFCtreatmentdescriptionclass of inhibitor

-0.984

Amikacinug/mL Amikacintranslation

0.594

Cap5-10ug/mL Capreomycintranslation

1.200

Rox10-50 ug/mL Roxithromycintranslation

1.186

SM2-5 ug/mL Streptomycintranslation

-1.296

Tet5-10 ug/mL Tetracyclinetranslation

-0.983

Rif0.2-5ug/mL Rifampicintranscription

0.597

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.514

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.048

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.136

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.683

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.321

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.131

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.957

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.032

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

2.156

NaN30.2-2 mM Sodium aziderespiration

-1.500

Nigericin50 uM Nigericinrespiration

-0.257

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.763

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.582

menadione6-10 ug/mL Menadionerespiration

0.816

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.695

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.795

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

2.412

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.006

NRP_1Non-replicating persistence stage 1dosRassociated

-0.035

Amp0.2mg/mL AmpicillincellWall

0.081

Cephalexin20-100 ug/mL CephalexincellWall

-0.221

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.681

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-1.007

EMB10-20 ug/mL EthambutolcellWall

-1.096

Eta12-40 ug/mL EthionamidecellWall

-0.714

INH0.2-0.4 ug/mL IsoniazidcellWall

-1.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.437

BZA0.12 mg/mL BenzamidearomaticAmides

0.486

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.289

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.050

H2O24 mM hydrogen peroxideDNAdamaging

-0.470

Levo10 ug/mL LevofloxacinDNAdamaging

0.748

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-2.056

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.048

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

0.990

Antimycin12.5-50 ug/mL Antimycin A?

-0.280

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.585

PA_110-50 ug/mL Antitubercular compound PA-1?

0.321

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.502

PA8240.2-2 ug/mL PA-824?

-0.985

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.137

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.562

Verapamil50 uM Verapamil?

-0.009

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.943

methoxatin10-20 ug/mL Methoxatin?